Shanghai, China

Ke Pan

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Jiangsu Yahong Meditech Co., Ltd., Asieris Pharmaceuticals (Shanghai) Co., Ltd., Asieris Pharmaceuticals (Shanghai) Co., Ltd.. Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ke Pan. Retrieved from https://idiyas.com/inventor/ke-pan-7kca06zi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 75.0

Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2009-2026

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Ke Pan - Revolutionizing Technology in Shanghai

Introduction: Ke Pan is a visionary inventor based in Shanghai, China, known for his groundbreaking contributions to the field of technology.

Latest Patents: Ke Pan holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies, showcasing his innovative mindset and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Ke Pan has worked with leading tech companies in Shanghai, driving research and development initiatives that have led to significant technological advancements.

Collaborations: Throughout his career, Ke Pan has collaborated with top researchers, engineers, and scientists both locally and internationally, fostering a culture of innovation and knowledge sharing.

Conclusion: Ke Pan's relentless pursuit of innovation and his passion for pushing the boundaries of technology make him a key figure in the inventor community, with his work continuing to inspire future generations of inventors worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…